fbpx

covid-19 Faq

  1. If you have current symptoms – SWAB 
  2. If you believe you have been exposed to COVID-19 or you’ve had symptoms in the past – BLOOD
    (You must be asymptomatic (free of symptoms) for at least seven (7) days prior to testing)

Standard office visit charges, nothing more. You are responsible for your insurance copays per your plan and no additional cost-sharing 

Our Pledge 

Be seen by professional medical office staff that will help you get triaged, referred to appropriate providers and tested

Full disclaimer: At this point all these tests are NOT FDA approved due to novelty of disease and number of subjects tested.. All tests are pending approval based on validation and have been granted emergency use. At this point, It is not known with certainty if having IgG antibody is a sign of immunity against reinfection

How Much Does COVID-19 Test Cost?  

You will receive separate lab fees, which will be paid by the fund. We are not a lab, we do not own the lab, nor have any financial interest in a lab.

Disclaimer:
You must be a US citizen or Resident to qualify for HRSA. If you are neither, we will charge you $99 for collection.

The good news is that The Families First Coronavirus Response Act enacted, mandates that COVID-19 testing is AVAILABLE to people WITHOUT INSURANCE, meaning that you won’t have to pay anything out of pocket related to COVID-19 diagnostic testing. 

If a person is diagnosed with COVID-19 and requires additional care, several insurers, including CMS, Aetna, Cigna, and Humana, Kaiser Permanente etc announced that they will waive all out-of-pocket costs for inpatient and outpatient services related to the treatment of COVID-19.

  1. What does it do: detects presence of an infection
  2. Not a blood test: In a patient with a COVID-19 infection, genetic material from SARS-CoV-2, the virus that causes COVID-19, is generally detectable in upper and lower respiratory specimens. Upper and lower respiratory specimens: are Nasopharyngeal (NP) swab/oropharyngeal (OP) swab, Nasopharyngeal wash/aspirate or nasal aspirate (NA), Nasal middle-turbinate (NMT) swab, also called Deep Nasal Swab, Anterior nares specimen (NS), Bronchoalveolar lavage, tracheal aspirate, pleural fluid, lung biopsy or sputum. In office testing is most commonly done by nasopharyngeal swab.
  3. Where is it done: an office, hospital or at home
  4. Time to detect:  5 – 45 minutes depending on type of manufacturer of test used.
  5. What does it test: genetic material from a sample is copied and then compared to the genetic sequence of the virus you’re trying to detect via reverse transcription polymerase chain reaction, (RT-PCR). In acute respiratory infections, molecular tests are routinely used to detect the presence of viral genetic material in a sample.
  6. Accuracy: Close to 100%. Since molecular tests detect the presence of viral genetic material, a positive resultindicates an active COVID-19 infection but does not rule out bacterial infections or co-infections with other viruses.
  7. FDA: not approved for COVID-19, but by emergency declaration was made available. Pending approval. 

  1. What does it do: identify those that were infected and have recovered. 
  2. Blood test: rely on detecting antibodies in a blood sample, usually obtained through a simple finger prick. These tests do not require special equipment to process the results, which allows them to be used in laboratories or at point-of-care.
  3. Where is it done: an office or hospital
  4. Time to detect: Serological tests are typically much faster than standard molecular tests. The FDA has authorized several serological tests, including one by Cellex that delivers results in about 15 minutes.  Previously, Bodysphere announced the approval of a 2 minute serological test, but they later clarified as the test was not actually approved.
  5. What does it test:  in exposure to a virus, the body develops antibodies, over several days or weeks. Antibodies are proteins your body makes when mounting a response against invading germs. The presence of immunoglobulin M (IgM) antibodies indicate recent exposure to COVID-19, while the presence of immunoglobulin G (IgG) antibodies indicate later-stage infection. The rapid response serological tests typically use a technique called enzyme-linked immunological assay (ELISA), which detects the presence of these antibodies to the virus.
  6. Accuracy: At this point close to 90% +/-. Since it can take several days for the body to develop an antibody response to the virus, serological tests may not be useful in identifying a current infection alone. They have the potential of producing a false negative, (a false result) when you actually have the infection. However, they can identify individuals who have had the infection and have recovered, suggesting that those people are now “immune” to the virus. It is still unclear how long any immunity lasts and if reinfection is possible.

FDA: authorization is still not required for these tests, but several companies have or plan to submit authorization requests, including Abbott, who recently announced the release of a serological test specific for IgG antibodies (later-stage infection) with plans to ship 1 million tests to customers immediately, and up to 20 million by the end of June.

 

CHECK OUT OUR GOOGLE REVIEWS